Forma Therapeutics

Mergers Acquisitions
Biotech

Novo Nordisk plows $1.1B for Forma Therapeutics with eye on SCD

Novo Nordisk is paying out $1.1 billion to acquire Forma Therapeutics, a biotech aiming to treat rare blood disorders like sickle cell disease (SCD).
Gabrielle Masson Sep 1, 2022 11:30am
cash money

Rigel bets $230M on Forma's leukemia drug

Aug 2, 2022 4:01pm
Parachute

FDA shores up executive team with 2 hires—Chutes & Ladders

Jul 1, 2022 9:30am
Forma Therapeutics

Forma builds case for FT-4202 in competitive sickle cell space

Mar 30, 2021 8:40am
Minimally invasive blood flow probe allows continuous monitoring Pixabay

Forma Therapeutics' IDH1 drug clears leukemia in 33% of patients

Oct 26, 2020 10:30am
Parachute

Olema Oncology brings on AZ vet Bohen as CEO—Chutes & Ladders

Sep 18, 2020 9:30am